European Summit of Industrial Biotechnology
14th-16thNovember 2017, Graz, Austria
The esib is the European platform for communication and networking for industrial biotechnology.
esib has already established itself as one of the biggest biotech conferences in Europe and an international platform for industrial biotechnology in multiple contexts. The event not only covers science but also deals with industrial needs and hopes, economic demands, funding resources or political aspirations and still leaves space for networking and recreation.
To register for the event, visit the event website here.
Abstracts are welcome from or scientific as well as non-scientific topics (not only political, economical or social issues but also project ideas, funding opportunities, responsible research etc.). Topics should be related to industrial biotechnology.
Deadline for abstract submission: 30th September, 2017
SynbiCITE four-day ‘More Business Acumen’ –
Building a Synthetic Biology-rich Biotech Business from Scratch.
19th – 23rd November 2017
Find out more here.
Synthetic Biology UK 2017
27th-28th November 2017, Manchester Conference Centre, UK.
The UK is a world leader in science and engineering, and Synthetic Biology has been identified as an important area for our continued success. Key to that success is a cohesive, vibrant and multidisciplinary community, open to collaboration, open to advances, supportive of young talent, and driven to exceptional research with meaningful outcomes. The SynBio UK conference aims to showcase UK Synthetic Biology research and to create a focal point for the community, embracing its diversity and fostering its growth and its engagement with society.
Held in the vibrant city of Manchester, where scientists first split the atom, the Manchester SynBio Centre, SYNBIOCHEM, specialises in synthetic biology for fine and speciality chemicals production, providing some focus towards chemicals and industrial biotechnology at this year’s meeting.
To view the scientific programme, please click here.
4th Synthetic Biology and Gene Editing Congress
4th and 5th December 2017, Novotel London West, London, UK
For the latest scientific advances in novel methods, investment opportunities and applications of synthetic biology and gene editing
Synthetic biology continues to be an exciting and rapidly developing area in the life sciences with the potential to revolutionise many aspects of society. As advances in gene editing and synthesis techniques continue to accelerate, this congress brings together experts in academia and industry to network and share ideas, and provides the opportunity for successful start-ups to showcase the commercial potential of synthetic biology. With a focus on healthcare and investment, this interactive meeting will allow you to keep up to date with cutting edge of of research and tool development, access to case studies on drug discovery, therapeutics and technologies, and the opportunity to make connections with academics, entrepreneurs, investors and businesses in your field.
To download the agenda, register for the event and additional information, click here.
Natural Products and Synthetic Biology: Parts and Pathways
21st to 24th January, 2018, Resort at Squaw Creek, Olympic Valley, California, USA.
Natural products, the structurally diverse family of small molecules produced by living organisms in an idiosyncratic fashion, have provided the basis for the majority of our therapeutic agents used to treat infectious diseases, cancer and immune disorders. Whole genome sequencing of producing organisms, especially bacteria and fungi, reveals that we have discovered only a fraction of these biosynthetically derived small molecules; a substantial fraction of natural product chemical space still represents “dark matter” (i.e., molecules predicted by bioinformatics analysis that have yet to be observed experimentally.
Diversity springs from variations in genetically encoded biosynthetic enzymes, environmental stimuli that regulate expression of these genes and the inherent combinatorial expansion resulting from multi-enzyme biosynthetic pathways. Closing this gap between our current inventory and the genomic potential has become an important goal for basic and applied science; synthetic biology coupled with bioinformatic analysis has become the primary research tool for this effort.Bioinformatic mining continues to reveal the enzymes and pathways that nature uses, and synthetic biology has begun to reassemble or refactor these pathways to produce known and unknown products in new hosts.
This conference brings together researchers in fields ranging from microbiology to botany, bioinformatics, gene synthesis and assembly, covering the spectrum from basic to industrial applications.
Event website, abstract submission, applications for scholarships and key deadlines, click here.
4th International Conference on Synthetic Biology and Tissue Engineering
Theme: Design and construct new biological parts for novel functions.
Click here to visit the event website.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 720793